Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynen

Showing results (561-570 of 624) with videos related to

Pageof 63
Sort By:
Physical Review Letters|April 8, 1996
Pochodzalla et al. replyPochodzalla, Möhlenkamp, Rubehn, et al.
Physical Review. C, Nuclear Physics|October 1, 1991
Intermediate mass fragments from 40Ar+197Au: Transition from the incomplete fusion to the participant spectator regimeMilkau, Berdermann, Berthier, et al.
Physical Review Letters|August 7, 1995
Probing the nuclear liquid-gas phase transitionPochodzalla, Möhlenkamp, Rubehn, et al.
The Lancet. Infectious Diseases|December 27, 2005
A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countriesRobert Colebunders, Kamya R Moses, John Laurence, et al.
BMC Infectious Diseases|April 6, 2026
Prevalence of nontuberculous mycobacteria isolates and pulmonary disease from respiratory tract samples in persons investigated for presumed tuberculosis from three West African countries, an analysis of three prospective cohort studiesElizabeth Tabitha Abbew, Souleymane Mahamadou Bassirou, Isiyaku Ahmadu, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 12, 2025
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern AfricaAlfred Kipyegon Keter, Alastair Van Heerden, Tom Decroo, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
Christian A Hudert, Martin Jankofsky, Verena Keitel-Anselmino, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Pageof 63

Showing results (561-570 of 624) with videos related to

Sort By:
Pageof 63
Physical Review Letters|April 8, 1996
Pochodzalla et al. replyPochodzalla, Möhlenkamp, Rubehn, et al.
Physical Review. C, Nuclear Physics|October 1, 1991
Intermediate mass fragments from 40Ar+197Au: Transition from the incomplete fusion to the participant spectator regimeMilkau, Berdermann, Berthier, et al.
Physical Review Letters|August 7, 1995
Probing the nuclear liquid-gas phase transitionPochodzalla, Möhlenkamp, Rubehn, et al.
The Lancet. Infectious Diseases|December 27, 2005
A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countriesRobert Colebunders, Kamya R Moses, John Laurence, et al.
BMC Infectious Diseases|April 6, 2026
Prevalence of nontuberculous mycobacteria isolates and pulmonary disease from respiratory tract samples in persons investigated for presumed tuberculosis from three West African countries, an analysis of three prospective cohort studiesElizabeth Tabitha Abbew, Souleymane Mahamadou Bassirou, Isiyaku Ahmadu, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 12, 2025
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern AfricaAlfred Kipyegon Keter, Alastair Van Heerden, Tom Decroo, et al.
Zeitschrift Fur Gastroenterologie|June 22, 2026
Christian A Hudert, Martin Jankofsky, Verena Keitel-Anselmino, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Pageof 63